US equities |
NVDA $239.32 ▲+0.18% MU $1,047.25 ▼-1.57% SPCX $172.53 ▲+0.84% MRVL $287.25 ▲+5.90% AMD $650.32 ▲+2.94% INTC $113.34 ▼-2.45% SNDK $1,658.57 ▼-2.68% AVGO $376.75 ▲+3.93%
FinancialContent

Latest News about GLPGF

Recent news which mentions GLPGF

Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
Tickers GLPG GLPGF
Tags Market News Biotech Health Care
From Benzinga
Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease
Tickers GILD GLPG GLPGF
Tags Benzinga News Briefs
From Benzinga
Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks
Tickers GILD GLPG GLPGF
Tags Market News Biotech GILD
From Benzinga
Galapagos' Another Psoriasis Candidate Shows Efficacy, Safety Profile In Mid-Stage Study
Tickers GLPG GLPGF
Tags General GLPGF Briefs
From Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
Tickers GLPG GLPGF
Tags General ulcerative colitis Briefs
From Benzinga